CNS Products Primed For “Breakthrough” Benefits
Tufts study indicates early talks with FDA could particularly help central nervous system product sponsors and their long clinical development programs.
Tufts study indicates early talks with FDA could particularly help central nervous system product sponsors and their long clinical development programs.